ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "80f53487-4926-4b5a-8b73-ecf853fdedcd"}, "_deposit": {"id": "2016187", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "2016187"}, "status": "published"}, "_oai": {"id": "oai:u-ryukyu.repo.nii.ac.jp:02016187", "sets": ["1642838216134", "1642838412624"]}, "author_link": [], "item_1617186331708": {"attribute_name": "Title", "attribute_value_mlt": [{"subitem_1551255647225": "[症例報告]遺伝子治療が抱える安全問題 : ウイルスベクターの安全性", "subitem_1551255648112": "ja"}, {"subitem_1551255647225": "Safety problems for gene therapy : Safety issues of virus vector", "subitem_1551255648112": "en"}]}, "item_1617186419668": {"attribute_name": "Creator", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "関口, 恵史", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "石田, 昭彦", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "新垣, 榮", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "安澄, 文興", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "Sekiguchi, Keishi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Ishida, Akihiko", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Arakaki, Sakae", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Yasuzumi, Fumioki", "creatorNameLang": "en"}]}]}, "item_1617186476635": {"attribute_name": "Access Rights", "attribute_value_mlt": [{"subitem_1522299639480": "open access", "subitem_1600958577026": "http://purl.org/coar/access_right/c_abf2"}]}, "item_1617186499011": {"attribute_name": "Rights", "attribute_value_mlt": [{"subitem_1522650717957": "ja", "subitem_1522651041219": "琉球医学会"}]}, "item_1617186609386": {"attribute_name": "Subject", "attribute_value_mlt": [{"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "gene therapy"}, {"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "safety test"}, {"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "virus vector"}, {"subitem_1522299896455": "en", "subitem_1522300014469": "Other", "subitem_1523261968819": "replication competent virus (RCV)"}]}, "item_1617186626617": {"attribute_name": "Description", "attribute_value_mlt": [{"subitem_description": "Gene therapy has made remarkable progress in recent years with revision of its guidelines in Europe and America. These guidelines deal with an extensive range of safety issues. Viruses used in gene delivery systems make up seventy percent of vectors and play an important role in gene therapy. However these viruses cause a lot of pathological problems. These problems need to be considered and tested. Tests for replication competent virus (RCV), proteins derived from vectors, undesirable immune response, etc. are recommended to be conducted using these guidelines. The test for RCV is necessary for safety measures. A lot can still be done in the development of gene therapy. The safety issues are discussed not only for medical concerns (e.g. safety test), but also for the operations of the manufacturer. These discussions may contribute to the quality of medicines and reagents. The guidelines just guides the general concept for gene therapy, therefore, it is desired that we should have more discussions on safety issues, and organize conferences between research institutes and the government.", "subitem_description_type": "Other"}, {"subitem_description": "論文", "subitem_description_type": "Other"}]}, "item_1617186643794": {"attribute_name": "Publisher", "attribute_value_mlt": [{"subitem_1522300295150": "ja", "subitem_1522300316516": "琉球医学会"}, {"subitem_1522300295150": "en", "subitem_1522300316516": "Ryukyu Medical Association"}]}, "item_1617186702042": {"attribute_name": "Language", "attribute_value_mlt": [{"subitem_1551255818386": "jpn"}]}, "item_1617186920753": {"attribute_name": "Source Identifier", "attribute_value_mlt": [{"subitem_1522646500366": "ISSN", "subitem_1522646572813": "1346888X"}, {"subitem_1522646500366": "ISSN", "subitem_1522646572813": "0289-1530"}, {"subitem_1522646500366": "NCID", "subitem_1522646572813": "AN10369445"}]}, "item_1617186941041": {"attribute_name": "Source Title", "attribute_value_mlt": [{"subitem_1522650068558": "ja", "subitem_1522650091861": "琉球医学会誌 = Ryukyu Medical Journal"}]}, "item_1617187056579": {"attribute_name": "Bibliographic Information", "attribute_value_mlt": [{"bibliographicIssueNumber": "3", "bibliographicPageEnd": "148", "bibliographicPageStart": "145", "bibliographicVolumeNumber": "20"}]}, "item_1617258105262": {"attribute_name": "Resource Type", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_1617265215918": {"attribute_name": "Version Type", "attribute_value_mlt": [{"subitem_1522305645492": "VoR", "subitem_1600292170262": "http://purl.org/coar/version/c_970fb48d4fbd8a85"}]}, "item_1617605131499": {"attribute_name": "File", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_access", "download_preview_message": "", "file_order": 0, "filename": "v20p145.pdf", "future_date_message": "", "is_thumbnail": false, "mimetype": "", "size": 0, "url": {"objectType": "fulltext", "url": "https://u-ryukyu.repo.nii.ac.jp/record/2016187/files/v20p145.pdf"}, "version_id": "b9c60706-ca76-4c22-a637-f3fde8fd3273"}]}, "item_title": "[症例報告]遺伝子治療が抱える安全問題 : ウイルスベクターの安全性", "item_type_id": "15", "owner": "1", "path": ["1642838216134", "1642838412624"], "permalink_uri": "http://hdl.handle.net/20.500.12000/0002016187", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2010-07-02"}, "publish_date": "2010-07-02", "publish_status": "0", "recid": "2016187", "relation": {}, "relation_version_is_last": true, "title": ["[症例報告]遺伝子治療が抱える安全問題 : ウイルスベクターの安全性"], "weko_shared_id": -1}
  1. 学術雑誌論文
  2. 琉球医学会
  3. 琉球医学会誌
  4. 20巻3号
  1. 部局別インデックス
  2. その他

[症例報告]遺伝子治療が抱える安全問題 : ウイルスベクターの安全性

http://hdl.handle.net/20.500.12000/0002016187
http://hdl.handle.net/20.500.12000/0002016187
2499504d-6a4b-49b0-967c-b0b90eec2797
名前 / ファイル ライセンス アクション
v20p145.pdf v20p145.pdf
Item type デフォルトアイテムタイプ(フル)(1)
公開日 2010-07-02
タイトル
タイトル [症例報告]遺伝子治療が抱える安全問題 : ウイルスベクターの安全性
言語 ja
タイトル
タイトル Safety problems for gene therapy : Safety issues of virus vector
言語 en
作成者 関口, 恵史

× 関口, 恵史

ja 関口, 恵史

Search repository
石田, 昭彦

× 石田, 昭彦

ja 石田, 昭彦

Search repository
新垣, 榮

× 新垣, 榮

ja 新垣, 榮

Search repository
安澄, 文興

× 安澄, 文興

ja 安澄, 文興

Search repository
Sekiguchi, Keishi

× Sekiguchi, Keishi

en Sekiguchi, Keishi

Search repository
Ishida, Akihiko

× Ishida, Akihiko

en Ishida, Akihiko

Search repository
Arakaki, Sakae

× Arakaki, Sakae

en Arakaki, Sakae

Search repository
Yasuzumi, Fumioki

× Yasuzumi, Fumioki

en Yasuzumi, Fumioki

Search repository
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
権利情報
言語 ja
権利情報 琉球医学会
主題
言語 en
主題Scheme Other
主題 gene therapy
主題
言語 en
主題Scheme Other
主題 safety test
主題
言語 en
主題Scheme Other
主題 virus vector
主題
言語 en
主題Scheme Other
主題 replication competent virus (RCV)
内容記述
内容記述タイプ Other
内容記述 Gene therapy has made remarkable progress in recent years with revision of its guidelines in Europe and America. These guidelines deal with an extensive range of safety issues. Viruses used in gene delivery systems make up seventy percent of vectors and play an important role in gene therapy. However these viruses cause a lot of pathological problems. These problems need to be considered and tested. Tests for replication competent virus (RCV), proteins derived from vectors, undesirable immune response, etc. are recommended to be conducted using these guidelines. The test for RCV is necessary for safety measures. A lot can still be done in the development of gene therapy. The safety issues are discussed not only for medical concerns (e.g. safety test), but also for the operations of the manufacturer. These discussions may contribute to the quality of medicines and reagents. The guidelines just guides the general concept for gene therapy, therefore, it is desired that we should have more discussions on safety issues, and organize conferences between research institutes and the government.
内容記述
内容記述タイプ Other
内容記述 論文
出版者
言語 ja
出版者 琉球医学会
出版者
言語 en
出版者 Ryukyu Medical Association
言語
言語 jpn
資源タイプ
資源タイプ journal article
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 1346888X
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 0289-1530
収録物識別子
収録物識別子タイプ NCID
収録物識別子 AN10369445
収録物名
言語 ja
収録物名 琉球医学会誌 = Ryukyu Medical Journal
書誌情報
巻 20, 号 3, p. 145-148
戻る
0
views
See details
Views

Versions

Ver.1 2022-02-22 04:16:29.902927
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3